Fiona M. Frame
Wentworth Way
York, ENG, United Kingdom
York, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Inhibition of c-FLIP alongside TRAIL treatment suppresses prostate cancer stem cell activity.
Journal: British journal of cancer
Published: June 04, 2025
FUT8 Is a Critical Driver of Prostate Tumour Growth and Can Be Targeted Using Fucosylation Inhibitors.
Journal: Cancer medicine
Published: February 13, 2025
Raman spectroscopy reveals oxidative stress-induced metabolic vulnerabilities in early-stage AR-negative prostate-cancer versus normal-prostate cell lines.
Journal: Scientific reports
Published: April 03, 2024
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer.
Journal: Communications biology
Published: April 11, 2023
ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.
Journal: The Journal of pathology
Published: February 28, 2023
Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth.
Journal: Oncogene
Published: September 22, 2022
Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity in Prostate Cancer.
Journal: Journal of medicinal chemistry
Published: February 25, 2022
ETS transcription factor ELF3 (ESE-1) is a cell cycle regulator in benign and malignant prostate.
Journal: FEBS open bio
Published: December 23, 2021
Overexpression of Placental Growth Factor in Stromal Cells from Benign Prostatic Hyperplasia: Another Piece in the Puzzle?
Journal: European urology open science
Published: August 14, 2020
Assessing the Advantages, Limitations and Potential of Human Primary Prostate Epithelial Cells as a Pre-clinical Model for Prostate Cancer Research.
Journal: Advances in experimental medicine and biology
Published: October 03, 2019
Last Updated: 09/26/2026